MS can be a challenging disease but a healthy, active lifestyle and medical therapies can help manage the symptoms – and offer hope to those living with the condition.
Academic rigour, journalistic flair
Articles on Multiple Sclerosis
Displaying 1 - 20 of 49 articles
People who take antiretroviral drugs have a much lower risk of getting multiple sclerosis – especially women.
Fifteen patients receiving an experimental stem cell therapy to treat advanced MS didn’t have the expected deteroriation in their condition.
In the past two decades, technology has allowed scientists to learn so much more about the human body and its microbiomes. These discoveries may pave the way to new therapies.
Recent research has shown there’s a link between multiple sclerosis and Epstein-Barr virus. A new study brings us closer to understanding the nature of this connection.
Researchers are working to determine how and which cannabis products can help those suffering from chronic pain or serious illness. But science is having a hard time keeping up with the booming market.
The gut microbiome plays a big role in mediating how the immune system responds to perceived threats, which include the body’s own nerves.
Microglia, immune cells disguised as brain cells, are known as the janitors of the brain. Dialing up their usual duties just enough could provide an avenue to treat neurodegenerative disease.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
The causes of multiple sclerosis (MS) are complex, but recent research found Epstein Barr virus, the same virus that causes mononucleosis, is an environmental trigger for MS.
Disabled single mother Shakira Hussein reflects on her secret weapon against adversity. Adalya, her ‘excessively mature’ daughter, appointed herself her mother’s carer and fierce protector from age 9.
COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
Getting glandular fever between ages 11 and 19 is associated with a significantly increased risk of getting MS after age 20.
Infections diagnosed in a hospital between ages 11 and 19 are associated with an increased risk of multiple sclerosis.
Our gut microbes play a key role in sending and receiving signals that influence the brain.
This antibody protects patients from viruses, even while on immunosuppressant drugs.
Obesity in young people today may contribute up to 14% of overall risk of multiple sclerosis in 2035.
Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
Our research has found a way of switching immune system cells from attacking to protecting.
When people lose their speech, they can stop working and friends can drift away. Here’s what we can do to help them get the rehabilitation they need.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Honorary Professor, Epidemiology, UCL
-
Professor of Electrical Engineering and Bioengineering, Tau Beta Pi Eminent Engineer, University of South Florida
-
Postdoctoral Associate in Neuroscience, University of Florida
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor- Departments of Medical Microbiology & Immunology and Dermatology | Member- Foods For Health Institute | Member- Comprehensive Cancer Center | Director- Autoimmunity | Director- Immune Monitoring, University of California, Davis
-
Laboratory Head, Florey Institute of Neuroscience and Mental Health
-
McKenzie Postdoctoral Fellow; Writer and researcher, National Centre for Excellence in Islamic Studies, The University of Melbourne
-
Post-doctoral Researcher, Harvard University
-
Research Assistant, University of Bristol
-
Clinical Professor of Internal Medicine, University of Iowa
-
Associate Professor of Medicine, Harvard University
-
Clinical Associate Professor, University of Nottingham
-
Medical student, University of California, Davis
-
Lecturer in Immunology, Edinburgh Napier University
-
Adjunct professor, Department of Health Policy & Management, George Washington University
